IVD Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Nanoparticle Formulated (Organic, Inorganic, and Carbon-based Nanoparticles), By Organic Nanoparticle Formulated, By Inorganic Nanoparticle Formulated, By Scale of Operation, Region, And Segment Forecasts, 2025-2034
IVD Contract Manufacturing Market Size is valued at 15.88 billion in 2024 and is predicted to reach 50.50 billion by the year 2034 at a 12.4% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
- The growing occurence of infectious diseases and the need for early diagnosis drive the demand for IVD devices, which in turn drives the growth of the IVD contract manufacturing market.
- Increasing regulatory complexities are driving IVD companies to outsource manufacturing to contract manufacturers, driving growth in the IVD Contract Manufacturing Market.
- Asia Pacific region dominated the 2023 market and accounted for a global revenue share.
- The certifications and appprovals are one of the key challenges hindering the growth of the IVD contract manufacturing market.
In vitro diagnostics (IVDs) are medical instruments/devices that use biological samples, such as blood or tissue, to diagnose various diseases and infections. IVD tests and assays range from simple tests like SARS-CoV-2 tests to complex laboratory IVD tools.
The global IVD market is the largest segment of the medical technology industry and is expanding with healthcare investments and an increasing focus on early detection and preventive care. The IVD industry is constantly evolving to meet the needs of clinical demands and personalized treatments.
The main reasons for the growth of this market are increasing demand for cheaper and better products, IVD OEMs gaining a foothold in the capital market, and the reduced risk of development failure. Additionally, the emergence of CMO facilities in various countries will likely boost the IVD contract manufacturing market in the next few years. However, growing shortages of skilled workers, the risk of patent infringement and other concerns about intellectual property security are holding back business growth.
Competitive Landscape:
Some of the Key Players in the IVD Contract Manufacturing Market :
- Avioq Inc.
- Biokit
- Celestica Inc.
- Cenogenics Corporation
- Cone Bioproducts
- Fujirebio
- Invetech
- Jabil Inc.
- Kimball Electronics, Inc.
- Kmc Systems
- Meridian Biosciences
- Nemera
- Nolato Gw, Inc.
- Nova Biomedical
- Phillips Medsize Corporation
- Sanmina Corporation
- Savyon Diagnosticss
- Stratec
- Te Connectivity Ltd.
- Thermofisher
- Viant Medical Holdings Inc.
- West Pharmaceutical Services
- Other Prominent Players
Market Segmentation:
The IVD contract manufacturing market is segmented based on device type, technology, and services. The device type segment comprises IVD Equipment and IVD Consumables. By technology, the market is bifurcated into immunoassay, clinical chemistry, molecular diagnostics, microbiology, hematology, coagulation & hemostasis, and others. By services, the market is categorized into manufacturing services, assay development services, and other services.
The IVD Equipment is expected to drive the IVD contract manufacturing market in the upcoming years
IVD contract manufacturing is surging rapidly. There are many reasons why businesses choose to outsource their IVD production. Maybe they have insufficient facilities for manufacturing large quantities in-house, or they don't have the necessary skills. Here, contractor manufacturers play an essential role in providing high-quality, low-cost, and efficient products as compared to what businesses can achieve on their own. Moreover, contracting companies can often provide more services than the business itself can provide.
This contracting facility is also beneficial for startups and small-scale companies to design, produce and sell their equipment. For instance, in November 2022, Jabil Inc. expanded its developmental capabilities by opening a design center in Wrolaw, Poland. This would allow the company to develop leading-edge technologies for multiple industries, including the automotive and healthcare sectors.
The Assay Development segment is growing at the highest rate in the IVD contract manufacturing market
Many outsourced companies in the IVD field choose to offer assay development services as they have limited financial capacity. Factors such as resource availability, growth and efficiency of R&D, reduced development time, lower cost, high efficiency, and expertise in assay development are considered to be the driving factors for the IVD contract manufacturing market.
Regionally, Asia Pacific led the IVD contract manufacturing market in 2022
Asia Pacific IVD contract manufacturing market dominated in 2022 and is expected to continue the same over the forecast period 2023-2031. The growth of this market can be attributed to rising demand for in vitro diagnostic tests, increased prevalence of diseases & infections, and growing mergers and acquisitions in the IVD sector.
Recent Developments:
- In March 2024, Fujirebio and Beckman Coulter Extended Their Collaboration to Develop Blood-Based Neurodegenerative Disease Diagnostics That Are Patient-Friendly. Fujirebio and Beckman Coulter worked together to develop novel biomarkers that corresponded with monoclonal antibody-based Alzheimer's disease therapeutics that were recently approved.
IVD Contract Manufacturing Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 15.88 Bn |
| Revenue Forecast In 2034 | USD 50.50 Bn |
| Growth Rate CAGR | CAGR of 12.4% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Device Type, By Technology, By Services |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | Avioq Inc., Biokit, Celestica Inc., Cenogenics Corporation, Cone Bioproducts, Fujirebio, Invetech, Jabil Inc., Kimball Electronics, Inc., Kmc Systems, Meridian Biosciences, Nemera, Nolato Gw, Inc., Nova Biomedical, Phillips Medsize Corporation, Sanmina Corporation, Savyon Diagnosticss, Stratec, Te Connectivity Ltd., Thermofisher, Viant Medical Holdings Inc., West Pharmaceutical Services, And Others. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of IVD Contract Manufacturing Market -
IVD Contract Manufacturing Market By Device Type-
- IVD Equipment
- IVD Consumables
IVD Contract Manufacturing Market By Technology-
- Immunoassay
- Clinical Chemistry
- Molecular Diagnostics
- Microbiology
- Hematology
- Coagulation and Hemostasis
- Others
IVD Contract Manufacturing Market By Services-
- Manufacturing Services
- Assay Development Services
- Other Services
IVD Contract Manufacturing Market By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
IVD Contract Manufacturing Market Size is valued at 15.88 billion in 2024 and is predicted to reach 50.50 billion by the year 2034
IVD Contract Manufacturing Market expected to grow at a 12.4% CAGR during the forecast period for 2025-2034
Avioq Inc., Biokit, Celestica Inc., Cenogenics Corporation, Cone Bioproducts, Fujirebio, Invetech, Jabil Inc., Kimball Electronics, Inc., Kmc Systems,
IVD Contract Manufacturing Market is segmented based on device type, technology, and services.
Asia Pacific region is leading the IVD Contract Manufacturing Market.